Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   The human oral microbiome and risk of colorectal cancer within three prospective cohort studies in the United States
  2. Vogtmann, Emily; Yano, Yukiko; Zouiouich, Semi; Hua,Xing; Wan, Yunhu; Purandare, Vaishnavi; Li, Shilan; Dagnall,Casey; Jones, Kristine; Hicks,Belynda; Hutchinson,Amy; Caporaso, J Gregory; Wheeler, William; Huang, Wen-Yi; Freedman, Neal D; Sandler, Dale P; Beane Freeman, Laura E; Liao, Linda M; Gail, Mitchell H; Shi, Jianxin; Abnet, Christian C; Sinha, Rashmi
  3. Cancer. 2025, Mar 15; 131(6): e35802.
  1. 2.   Novel Cytotoxic Sesquiterpene Coumarin Ethers and Sulfur-Containing Compounds from the Roots of Ferula turcica
  2. Eruçar, Fatma Memnune; Senadeera, Sarath P D; Wilson,Jennifer; Goncharova,Katya; Beutler,John; Miski, Mahmut
  3. Molecules (Basel, Switzerland). 2023, Jul 28; 28(15):
  1. 3.   RAS internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling
  2. Nelson, Andrew C; Turbyville,Tommy; Dharmaiah,Sathiya; Rigby,Megan; Yang, Rendong; Wang, Ting-You; Columbus,John; Stephens, Robert; Taylor,Troy; Sciacca, Drew; Onsongo, Getiria; Sarver, Anne; Subramanian, Subbaya; Nissley,Dwight; Simanshu,Dhirendra; Lou, Emil
  3. The Journal of biological chemistry. 2020, JUL 10; 295(28): 9335-9348.
  1. 4.   Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model
  2. Park, Jun Ho; Han, Qinghong; Zhao, Ming; Tan, Yuying; Higuchi, Takashi; Yoon, Sang Nam; Sugisawa, Norihiko; Yamamoto, Jun; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Hoffman, Robert M
  3. Tissue & cell. 2019, Dec; 61: 109-114.
  1. 5.   Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse model
  2. Park, Jun Ho; Zhao, Ming; Han, Qinghong; Sun, Yu; Higuchi, Takashi; Sugisawa, Norihiko; Yamamoto, Jun; Singh,Shree Ram; Clary, Bryan; Bouvet, Michael; Hoffman, Robert M
  3. Biochemical and biophysical research communications. 2019, Oct 15; 518(2): 306-310.
  1. 6.   The Natural Product Butylcycloheptyl Prodiginine Binds Pre-miR-21, Inhibits Dicer-Mediated Processing of Pre-miR-21, and Blocks Cellular Proliferation
  2. Matarlo, Joe S; Haugh Krumpe,Lauren; Heinz,Will; Oh, Daniel; Shenoy, Shilpa R; Thomas,Cheryl; Goncharova,Katya; Lockett,Stephen; O'Keefe,Barry
  3. Cell chemical biology. 2019, Aug 15; 26(8): 1133-1142.e4.
  1. 7.   Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis
  2. Yoon, Sang Nam; Park, Jun Ho; Lwin, Thinzar M; Miyake, Kentaro; Singh,Shree Ram; Hoffman, Robert M; Bouvet, Michael
  3. Anticancer research. 2019, Aug; 39(8): 4065-4071.
  1. 8.   Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells
  2. Park, Jun Ho; Zhao, Ming; Oshiro, Hiromichi; Miyake, Kentaro; Higuchi, Takashi; Reynoso, Jose; Razmjooei, Sahar; Bouvet, Michael; Clary, Bryan; Zhang, Zhiying; Sugisawa, Norihiko; Yamamoto, Jun; Singh,Shree Ram; Hoffman, Robert M
  3. Anticancer research. 2019, Jul; 39(7): 3463-3467.
  1. 9.   Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells
  2. Desir, Snider; Wong, Phillip; Turbyville,Tommy; Chen,De; Shetty, Mihir; Clark, Christopher; Zhai, Edward; Romin, Yevgeniy; Manova-Todorova, Katia; Starr, Timothy K; Nissley,Dwight; Steer, Clifford J; Subramanian, Subbaya; Lou, Emil
  3. Cancers. 2019, Jun 26; 11(7): pii: E892.
  1. 10.   A mutational comparison of adult and adolescent and young adult (AYA) colon cancer
  2. Tricoli, James V; Boardman, Lisa A; Patidar, Rajesh; Sindiri, Sivasish; Jang, Jin S; Walsh, William; McGregor, Paul M; Camalier, Corinne; Mehaffey, Michele G; Furman, Wayne L; Bahrami, Armita; Williams, Mickey; Lih, Chih-Jian; Conley, Barbara A; Khan, Javed
  3. Cancer. 2018, Mar 1; 124(5): 1070-1082.
  1. 11.   Characterization of Potent and Selective Iodonium-Class Inhibitors of NADPH Oxidases.
  2. Lu, Jiamo; Risbood, Prabhakar; Kane, Charles T; Hossain, Md Tafazzal; Anderson, Larry; Hill, Kimberly; Monks, Patricia; Wu, Yongzhong; Antony, Smitha; Juhasz, Agnes; Liu, Han; Jiang, Guojian; Harris, Erik; Roy, Krishnendu; Meitzler, Jennifer L; Konaté, Mariam; Doroshow, James H
  3. Biochemical Pharmacology. 2017, Nov 01; 143: 25-38.
  1. 12.   NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction
  2. Juhasz, Agnes; Markel, Susan; Gaur, Shikha; Liu, Han; Lu, Jiamo; Jiang, Guojian; Wu, Xiwei; Antony, Smitha; Wu, Yongzhong; Melillo, Giovanni; Meitzler, Jennifer L; Haines, Diana; Butcher, Donna; Roy, Krishnendu; Doroshow, James H
  3. Journal of Biological Chemistry. 2017, May 12; 292(19): 7866-7887.
  1. 13.   Biological Assessment of Triazine Dendrimer: Toxicological Profiles, Solution Behavior, Biodistribution, Drug Release and Efficacy in a PEGylated, Paclitaxel Construct
  2. Lo, S. T.; Stern, S.; Clogston, J. D.; Zheng, J. W.; Adiseshaiah, P. P.; Dobrovolskaia, M.; Lim, J. D.; Patri, A. K.; Sun, X. K.; Simanek, E. E.
  3. Molecular Pharmaceutics. 2010, Jul-Aug; 7(4): 993-1006.
  1. 14.   Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis
  2. Goodman, J. E.; Mechanic, L. E.; Luke, B. T.; Ambs, S.; Chanock, S.; Harris, C. C.
  3. International Journal of Cancer. 2006, Apr; 118(7): 1790-1797.
  1. 15.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 16.   Proline oxidase, a proapoptotic gene, is induced by troglitazone - Evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms
  2. Pandhare, J.; Cooper, S. K.; Phang, J. M.
  3. Journal of Biological Chemistry. 2006, JAN 27; 281(4): 2044-2052.
  1. 17.   Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Belousov, P. V.; Kuz'mina, K. E.; Radko, B. V.; Longpre, F.; Lagarkova, M. A.; Kadachigova, T. S.; Gurova, O. V.; Meshcheryakov, A. A.; Lichinitser, M. R.; Knuth, A.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. International Journal of Cancer. 2005, DEC 10; 117(5): 800-806.
  1. 18.   Identification of celecoxib-modulated proteomic targets in colon cancer cell line, HCT-116
  2. Lou, J. R.; Xiao, Z.; Stauffer, S.; Fatima, N.; Conrads, T.; Veenstra, T.; Greenwald, P.; Ali, I.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2750S-2750S.
  1. 19.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 20.   Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Lagarkova, M. A.; Meshcheryakov, A. A.; Lichinitser, M. R.; Karbach, J.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunology Letters. 2005, AUG 15; 100(1): 88-93.
  1. 21.   A new synthetic agent with potent but selective cytotoxic activity against cancer
  2. Cholody, W. M.; Kosakowska-Cholody, T.; Hollingshead, M. G.; Hariprakasha, H. K.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2005, JUN 30; 48(13): 4474-4481.
  1. 22.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 23.   Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis
  2. Harman, F. S.; Nicol, C. J.; Marin, H. E.; Ward, J. M.; Gonzalez, F. J.; Peters, J. M.
  3. Nature Medicine. 2004 10(5): 481-483.
  1. 24.   Bisimidazoacridones induce a potent cytostatic effect in colon tumor cells that sensitizes them to killing by UCN-01
  2. Cholody, W. M.; Kosakowska-Cholody, T.; Michejda, C. J.
  3. Cancer Chemotherapy and Pharmacology. 2001 47(3): 241-249.
  1. 25.   Microsatellite instability is infrequent in azoxymethane-induced rat intestinal tumors: An assessment by capillary electrophoresis
  2. Walchle, C.; Diwan, B. A.; Shiao, Y. H.; Calvert, R. J.
  3. Toxicology and Applied Pharmacology. 1999 157(1): 9-15.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel